Hemp/CBD Litigation: Curaleaf Hit With Federal Class Action Lawsuit Alleging Securities Violations
Canna Law Blog
AUGUST 9, 2019
As this CNBC report explains, The FDA told the cannabis company earlier this week that it was ‘illegally selling’ CBD products with ‘unsubstantiated claims’ that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety.” The same care and research went into the development of Bido.
Let's personalize your content